Search | VHL Regional Portal

1.

[A case of sodium taurocholate cotransporting polypeptide deficiency manifesting as infantile cholestasis].

He, J Y; Shu, S N.

Zhonghua Er Ke Za Zhi ; 62(8): 788-790, 2024 Jul 23.

Article in Chinese | MEDLINE | ID: mdl-39039884

2.

[Rationalize the choose of pathogen detection methods to conduct precise anti-infection therapy].

Shu, S N.

Zhonghua Er Ke Za Zhi ; 61(8): 673-674, 2023 Aug 02.

Article in Chinese | MEDLINE | ID: mdl-37528004

Subject(s)

Anti-Bacterial Agents , Humans , Anti-Bacterial Agents/therapeutic use

3.

[Experts guidance on diagnosis and treatment of severe acute hepatitis of unknown origin in children].

Chen, T; Ma, K; Shu, S N; Chen, Y; Wang, X J; Chen, G; Liu, T L; Chen, Z S; Fang, F; Luo, X P; Ning, Qin.

Zhonghua Er Ke Za Zhi ; 60(7): 621-626, 2022 Jul 02.

Article in Chinese | MEDLINE | ID: mdl-35768347

Subject(s)

Hepatitis , Acute Disease , Child , Humans

4.

[A case of delayed-type cholesteryl ester storage disease derived from LIPA gene mutation].

Xiao, Z J; Liu, S X; Zou, B; Cheng, H H; Xu, H; Huang, Z H; Shu, S N.

Zhonghua Er Ke Za Zhi ; 60(4): 360-362, 2022 Apr 02.

Article in Chinese | MEDLINE | ID: mdl-35385947

Subject(s)

Cholesterol Ester Storage Disease , Cholesterol Ester Storage Disease/genetics , Humans , Mutation , Sterol Esterase/genetics

5.

[Rationalize empiric anti-infection therapy in children].

Shu, S N.

Zhonghua Er Ke Za Zhi ; 60(1): 76-77, 2022 Jan 02.

Article in Chinese | MEDLINE | ID: mdl-34986631

Subject(s)

Anti-Bacterial Agents , Anti-Bacterial Agents/therapeutic use , Child , Humans

6.

[Challenge and consideration of emerging and re-emerging infectious diseases in children].

Shu, S N.

Zhonghua Er Ke Za Zhi ; 59(8): 624-626, 2021 Aug 02.

Article in Chinese | MEDLINE | ID: mdl-34333912

Subject(s)

Communicable Diseases, Emerging , Child , Communicable Diseases, Emerging/epidemiology , Humans

7.

[Re-discussion on the diagnosis and treatment of cytomegalovirus hepatitis in children].

Riziki, Y N; Shu, S N.

Zhonghua Gan Zang Bing Za Zhi ; 29(1): 13-15, 2021 Jan 20.

Article in Chinese | MEDLINE | ID: mdl-33541018

ABSTRACT

Cytomegalovirus hepatitis, especially infants with cholestatic liver disease or abnormal liver function, is of great concern to pediatricians. Previously, cytomegalovirus infection was the recognized cause of the disease. Therefore, a comprehensive scientific understanding of cytomegalovirus hepatitis requires an understanding of the basic knowledge of cytomegalovirus infection. Concurrently, it is necessary to standardize the indications of antiviral treatment in combination with the child's age, immune status and other potential diseases to avoid the abuse of antiviral drugs.

Subject(s)

Antiviral Agents , Cytomegalovirus Infections , Hepatitis , Antiviral Agents/therapeutic use , Child , Cytomegalovirus , Cytomegalovirus Infections/diagnosis , Cytomegalovirus Infections/drug therapy , Ganciclovir/therapeutic use , Humans , Infant

Subject(s)

Subject(s)

Subject(s)

Subject(s)

Subject(s)

ABSTRACT

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL